Literature DB >> 29949208

Epstein-Barr virus post-transplant lymphoproliferative disease (PTLD) after hematopoietic stem cell transplantation.

Yuhua Ru1,2, Jia Chen1,2, Depei Wu1,2.   

Abstract

Epstein-Barr virus (EBV) viremia and post-transplant lymphoproliferative disease (PTLD) are severe complications after hematopoietic stem cell transplantation (HSCT). A series of risk factors have been found to predict EBV viremia and PTLD, including the T-cell depletion, reduced intensity conditioning, and alternative donor. The rituximab pre-emptive therapy could improve PTLD prognosis significantly, but the trigger of initiating rituximab pre-emptive therapy has not been well established. Additionally, EBV-specific cytotoxic T cell (CTL) is a promising approach to treat EBV-PTLD.
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  EB virus; hematopoietic stem cell transplantation; lymphoproliferative disease

Mesh：

Substances：

Year:  2018        PMID： 29949208     DOI： 10.1111/ejh.13131

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN： 0902-4441            Impact factor:   2.997


  7 in total

1.  Identification and Treatment of Tuberculosis in Pediatric Recipients of Allogeneic Hematopoietic Stem Cell Transplantation: Case Series and Review of the Literature.

Authors:  Xiaodong Wang; Uet Yu; Xiaonan Li; Chunjing Wang; Qian Zhang; Chunlan Yang; Xiaoling Zhang; Yu Zhang; Ying Wang; Yuejie Zheng; Jikui Deng; Weiguo Yang; Guosheng Liu; Guofang Deng; Sixi Liu; Feiqiu Wen
Journal:  Infect Drug Resist       Date:  2020-07-31       Impact factor: 4.003

2.  Features of Epstein-Barr Virus and Cytomegalovirus Reactivation in Acute Leukemia Patients After Haplo-HCT With Myeloablative ATG-Containing Conditioning Regimen.

Authors:  Yuhua Ru; Jinjin Zhu; Tiemei Song; Yiyang Ding; Ziling Zhu; Yi Fan; Yang Xu; Aining Sun; Huiying Qiu; Zhengming Jin; Xiaowen Tang; Yue Han; Chengcheng Fu; Suning Chen; Xiao Ma; Feng Chen; Jia Chen; Depei Wu
Journal:  Front Cell Infect Microbiol       Date:  2022-05-16       Impact factor: 6.073

3.  Epstein-Barr Virus-Induced Post-Transplant Lymphoproliferative Disorder of the Central Nervous System Successfully Treated with Chemo-immunotherapy.

Authors:  Hiroaki Inoue; Shinya Rai; Hirokazu Tanaka; J Luis Espinoza; Maiko Komori-Inoue; Hiroaki Kakutani; Shuji Minamoto; Takahiro Kumode; Shoko Nakayama; Yasuhiro Taniguchi; Yasuyoshi Morita; Takeshi Okuda; Yoichi Tatsumi; Takashi Ashida; Itaru Matsumura
Journal:  Viruses       Date:  2020-04-08       Impact factor: 5.048

4.  Impact of porcine cytomegalovirus on long-term orthotopic cardiac xenotransplant survival.

Authors:  Joachim Denner; Matthias Längin; Bruno Reichart; Luise Krüger; Uwe Fiebig; Maren Mokelke; Julia Radan; Tanja Mayr; Anastasia Milusev; Fabian Luther; Nicoletta Sorvillo; Robert Rieben; Paolo Brenner; Christoph Walz; Eckhard Wolf; Berit Roshani; Christiane Stahl-Hennig; Jan-Michael Abicht
Journal:  Sci Rep       Date:  2020-10-16       Impact factor: 4.379

5.  Successful low-dose chemotherapy for refractory Epstein-Barr virus-related post-transplant lymphoproliferative disorder following hematopoietic stem cell transplantation in a child with Wiskott-Aldrich syndrome.

Authors:  Bixin Xi; Chen Zhou; Yu Zhang
Journal:  Clin Case Rep       Date:  2021-05-24

6.  Epstein-Barr virus and cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation in patients with non-Hodgkin lymphoma: the prevalence and impacts on outcomes : EBV and CMV reactivation post allo-HCT in NHL.

Authors:  Yiyang Ding; Yuhua Ru; Tiemei Song; Lingchuan Guo; Xiang Zhang; Jinjin Zhu; Caixia Li; Zhengming Jin; Haiwen Huang; Yuqing Tu; Mimi Xu; Yang Xu; Jia Chen; Depei Wu
Journal:  Ann Hematol       Date:  2021-09-04       Impact factor: 3.673

7.  Gastrointestinal manifestations, risk factors, and management in patients with post-transplant lymphoproliferative disorder: A systematic review.

Authors:  William Reiche; Abubakar Tauseef; Ahmed Sabri; Mohsin Mirza; David Cantu; Peter Silberstein; Saurabh Chandan
Journal:  World J Transplant       Date:  2022-08-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.